Help - Search - Members - Calendar
Full Version: Charcot-Marie-Tooth-Disease
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Charcot-Marie-Tooth-Disease
  1. Adaptation by alternative rna splicing of slow troponin t isoforms in type 1 but not type 2 charcot-marie-tooth disease (0 replies)
  2. Nefl
    pro22arg mutation in charcot-marie-tooth disease type 1     (0 replies)
  3. Charcot-marie-tooth type x: unusual phenotype of a novel cx32 mutation (0 replies)
  4. Vincristine: peripheral nerve disorders in a patient with charcot-marie-tooth disease type 2: case report (0 replies)
  5. Vincristine: peripheral nerve disorders in a patient with charcot-marie-tooth disease type 2: case report. (0 replies)
  6. Compound heterozygous deletions of pmp22 causing severe charcot-marie-tooth disease of the dejerine-sottas disease phenotype (0 replies)
  7. Charcot-marie-tooth disease (0 replies)
  8. Mutation of fig4 causes a rapidly progressive, asymmetric neuronal degeneration (0 replies)
  9. Teen athlete with debilitating deformities back on feet after complex surgery at cedars-sinai medical center (0 replies)
  10. V osteotomy and ilizarov technique for residual idiopathic or neurogenic clubfeet. (0 replies)
  11. Message of hope. (0 replies)
  12. Ultrasound-guided peripheral regional blockade in patients with charcot-marie-tooth disease: a review of three cases. (0 replies)
  13. Ultrasound-guided peripheral regional blockade in patients with charcot-marie-tooth disease: a review of three cases: [bloc regional peripherique echoguide chez les patients souffrant de la maladie de charcot-marie-tooth: compte-rendu de trois cas]. (0 replies)
  14. Bilateral trigeminal neuralgia and charcot-marie-tooth disease: diagnosis and successful microsurgical treatment of bilateral neurovascular compression (0 replies)
  15. Bilateral trigeminal neuralgia and charcot-marie-tooth disease: diagnosis and successful microsurgical treatment of bilateral neurovascular compression. (0 replies)
  16. Oxford brookes study need more participants with muscular dystrophy, uk (0 replies)
  17. Immune effects of mesenchymal stem cells: implications for charcot-marie-tooth disease. (0 replies)
  18. Funding for charcot-marie-tooth disease research (0 replies)
  19. Charcot-marie-tooth disease research funding (0 replies)
  20. Severe neurotoxicities in a case of charcot-marie-tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia. (0 replies)
  21. Charcot-marie-tooth and pain: correlations with neurophysiological, clinical, and disability findings (0 replies)
  22. Late-onset hmsn 2: further evidence of genetic heterogeneity (0 replies)
  23. Late-onset hereditary axonal neuropathies (0 replies)
  24. Distal hereditary motor neuropathy in korean patients with a small heat shock protein 27 mutation. (0 replies)
  25. Founder effect and estimation of the age of the c.892c>t (p.arg298cys) mutation in lmna associated to charcot-marie-tooth subtype cmt2b1 in families from north western africa (0 replies)
  26. Adaptation by alternative rna splicing of slow troponin t isoforms in type 1 but not type 2 charcot-marie-tooth disease. (0 replies)
  27. Magnetic resonance imaging findings of leg musculature in charcot-marie-tooth disease type 2 due to dynamin 2 mutation (0 replies)
  28. [short reports] increased prevalence of obstructive sleep apnoea in patients with charcot-marie-tooth disease: a case control study (0 replies)
  29. Founder effect and estimation of the age of the c.892c>t (p.arg298cys) mutation in lmna associated to charcot-marie-tooth subtype cmt2b1 in families from north western africa (0 replies)
  30. Sequential actions of myotubularin lipid phosphatases regulate endosomal pi(3)p and growth factor receptor trafficking. (0 replies)
  31. [letters to the editor] electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease (0 replies)
  32. Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease. (0 replies)
  33. Pressure characteristics in painful pes cavus feet resulting from charcot-marie-tooth disease. (0 replies)
  34. Increased severity over generations of charcot-marie-tooth disease type 1a (0 replies)
  35. Cerebral involvement in axonal charcot-marie-tooth neuropathy caused by mitofusin2 mutations (0 replies)
  36. Charcot-marie-tooth disease type 1b: marked phenotypic variation of the ser78leu mutation in five italian families (0 replies)
  37. Gap junction beta 1 (
    gjb1
    ) gene mutations in italian patients with x-linked charcot-marie-tooth disease     (0 replies)
  38. Estimating contraction level using root mean square amplitude in control subjects and patients with neuromuscular disorders. (0 replies)
  39. Charcot-marie-tooth disease (0 replies)
  40. Central nervous system signs in x-linked charcot-marie-tooth disease after hyperventilation. (0 replies)
  41. [neuroscience] loss of the inactive myotubularin-related phosphatase mtmr13 leads to a charcot-marie-tooth 4b2-like peripheral neuropathy in mice (0 replies)
  42. Comparison of two pcr-based molecular methods in the diagnosis of cmt 1a and hnpp diseases in chinese. (0 replies)
  43. Correlation between clinical/neurophysiological findings and quality of life in charcot-marie-tooth type 1a (0 replies)
  44. Benefits of interval-training on fatigue and functional capacities in charcot-marie-tooth disease (0 replies)
  45. The clinical spectrum associated with a chromosome 17 short arm proximal duplication (dup 17p11.2) in three patients (0 replies)
  46. Centocor removes lawsuit alleging remicade triggered charcot-marie-tooth disorder (0 replies)
  47. Capillary electrophoresis for the detection of pmp22 gene duplication: study in mexican patients (0 replies)
  48. Poor compliance with ankle-foot-orthoses in charcot-marie-tooth disease. (0 replies)
  49. Mitochondrial dynamics: to be in good shape to survive. (0 replies)
  50. Human oligodendrocytes express cx31.3: function and interactions with cx32 mutants. (0 replies)
  51. Sensory evaluation of the hands in patients with charcot-marie-tooth disease using semmes-weinstein monofilaments. (0 replies)
  52. A highly specific microarray method for point mutation detection. (0 replies)
  53. Volume 79, number 5: a chromosomal rearrangement hotspot can be identified from population genetic variation and is coincident with a hotspot for allelic recombination (99 replies)
  54. Cloning, expression and characterization of the murine orthologue of sbf2, the gene mutated in charcot-marie-tooth disease type 4b2. (0 replies)
  55. A chromosomal rearrangement hotspot can be identified from population genetic variation and is coincident with a hotspot for allelic recombination (0 replies)
  56. A chromosomal rearrangement hotspot can be identified from population genetic variation and is ... (0 replies)
  57. Effects of exercise and creatine on myosin heavy chain isoform composition in patients with charcot-marie-tooth disease (0 replies)
  58. Effects of exercise and creatine on myosin heavy chain isoform composition in patients with ... (0 replies)
  59. [papers] charcot-marie-tooth disease type 1a duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study (0 replies)
  60. [papers] charcot-marie-tooth disease type 1a duplication with severe paresis of the proximal ... (0 replies)
  61. Night splinting does not increase ankle range of motion in people with charcot-marie-tooth disease: a randomised, cross-over trial. (0 replies)
  62. Night splinting does not increase ankle range of motion in people with charcot-marie-tooth ... (0 replies)
  63. Comparison of cmt1a and cmt2: similarities and differences (0 replies)
  64. Comparison of cmt1a and cmt2: similarities and differences (0 replies)
  65. Is a novel i214m substitution in the nefl gene a cause of charcot-marie-tooth disease? functional analysis using cell culture models (0 replies)
  66. Is a novel i214m substitution in the nefl gene a cause of charcot-marie-tooth disease? ... (0 replies)
  67. Spine deformities in charcot-marie-tooth 4c caused by sh3tc2 gene mutations (0 replies)
  68. Evidence for involvement of tre-2 (usp6) oncogene, low-copy repeat and acrocentric heterochromatin in two families with chromosomal translocations (0 replies)
  69. Evidence for involvement of tre-2 (usp6) oncogene, low-copy repeat and acrocentric ... (0 replies)
  70. Mutation analysis of the pmp22, mpz, egr2, litaf, and gjb1 genes in korean patients with charcot-marie-tooth neuropathy type 1 (0 replies)
  71. Mutation analysis of the pmp22, mpz, egr2, litaf, and gjb1 genes in korean patients with ... (0 replies)
  72. How to assess the pathogenicity of mutations in charcot-marie-tooth disease and other diseases? (0 replies)
  73. How to assess the pathogenicity of mutations in charcot-marie-tooth disease and other diseases? (0 replies)
  74. Critical dependence of neurons on mitochondrial dynamics. (0 replies)
  75. Diagnosis of charcot-marie-tooth disease simplified by research (0 replies)
  76. Diagnosis of charcot-marie-tooth disease simplified by research (0 replies)
  77. Early onset severe and late-onset mild charcot-marie-tooth disease with mitofusin 2 (mfn2) mutations (0 replies)
  78. Mfn2 mutation distribution and genotype/phenotype correlation in charcot-marie-tooth type 2 (0 replies)
  79. Sponsorship Opportunity (0 replies)
  80. Mfn2 mutation distribution and genotype/phenotype correlation in charcot-marie-tooth type 2 (0 replies)
  81. Early onset severe and late-onset mild charcot-marie-tooth disease with mitofusin 2 (mfn2) mutations (0 replies)
  82. See your message here (0 replies)
  83. Sponsorship Opportunity (0 replies)
  84. [short reports] myelin protein zero mutation his39pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis (0 replies)
  85. [charcot-marie-tooth disorders: past, today and tomorrow.] (0 replies)
  86. [short reports] myelin protein zero mutation his39pro: hereditary motor and sensory neuropathy ... (0 replies)
  87. [charcot-marie-tooth disorders: past, today and tomorrow.] (0 replies)
  88. Microarray maph: accurate array-based detection of relative copy number in genomic dna (0 replies)
  89. Microarray maph: accurate array-based detection of relative copy number in genomic dna (0 replies)
  90. Pes cavus pathogenesis in charcot-marie-tooth disease type 1a (0 replies)
  91. Pes cavus pathogenesis in charcot-marie-tooth disease type 1a (0 replies)
  92. Simple mutation analysis in dominant demyelinating charcot-marie-tooth disease: three novel mutations (0 replies)
  93. Simple mutation analysis in dominant demyelinating charcot-marie-tooth disease: three novel ... (0 replies)
  94. The g526r glycyl-trna synthetase gene mutation in distal hereditary motor neuropathy type v (0 replies)
  95. The g526r glycyl-trna synthetase gene mutation in distal hereditary motor neuropathy type v (0 replies)
  96. Charcot-marie-tooth neuropathy type 2a:
    novel mutations in the mitofusin 2 gene (mfn2)     (0 replies)
  97. Charcot-marie-tooth neuropathy type 2a:
    novel mutations in the mitofusin 2 gene (mfn2)     (0 replies)
  98. Pregnancy in charcot-marie-tooth disease (0 replies)
  99. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy (0 replies)
  100. Pregnancy in charcot-marie-tooth disease (0 replies)
  101. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy (0 replies)
  102. Evaluation and treatment of hip dysplasia in charcot-marie-tooth disease. (0 replies)
  103. Evaluation and treatment of hip dysplasia in charcot-marie-tooth disease. (0 replies)
  104. New mutation of gap junction protein β1 (gjb1) gene in x-linked hereditary motor and sensory neuropathy (0 replies)
  105. New mutation of gap junction protein β1 (gjb1) gene in x-linked hereditary motor and sensory ... (0 replies)
  106. Electrodiagnostic studies in a murine model of demyelinating charcot-marie-tooth disease. (0 replies)
  107. Electrodiagnostic studies in a murine model of demyelinating charcot-marie-tooth disease. (0 replies)
  108. Molecular genetics studies in polish charcot-marie-tooth families. (0 replies)
  109. Molecular genetics studies in polish charcot-marie-tooth families. (0 replies)
  110. Mutations in the neurofilament light chain gene (nefl)--a study of a possible pathogenous effect. (0 replies)
  111. Mutations in the neurofilament light chain gene (nefl)--a study of a possible pathogenous effect. (0 replies)
  112. Mechanisms of disease: inherited demyelinating neuropathies--from basic to clinical research. (0 replies)
  113. [silver syndrome - case report.] (0 replies)
  114. Neuropathy progression in charcot-marie-tooth disease type 1a (0 replies)
  115. A novel
    gdap1
    q218e mutation in autosomal dominant charcot-marie-tooth disease     (0 replies)
  116. Ndrg1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states (0 replies)
  117. Mpz mutation g123s characterization: evidence for a complex pathogenesis in cmt disease (0 replies)
  118. Charcot-marie-tooth disease: a clinico-genetic confrontation (0 replies)
  119. Unusual presentation of hereditary neuropathy with liability to pressure palsies (0 replies)
  120. New motor system impairment diagnosing tool developed (0 replies)
  121. Identification of deletion and duplication genotypes of the pmp22 gene using pcr-rflp, competitive multiplex pcr, and multiplex ligation-dependent probe amplification: a comparison (0 replies)
  122. Differential expression patterns of ndrg family proteins in the central nervous system (0 replies)
  123. Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice (0 replies)
  124. California girl named 2008 mda national goodwill ambassador (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.